Traumatic brain injury affects approx. 15 million individuals annually worldwide. Cerebrolysin® is an add-on therapy to standard care for all these patients.
Please be advised that Cerebrolysin is not registered with the U.S. Food and Drug Administration (FDA) and is not approved for sale or distribution in the United States.
Cerebrolysin is a prescription medication for use under the supervision of an authorized health care professional.
For any medical inquiries, please consult with a healthcare professional.
